Page last updated: 2024-11-01

nifedipine and Ulcer

nifedipine has been researched along with Ulcer in 4 studies

Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.

Ulcer: A lesion on the surface of the skin or a mucous surface, produced by the sloughing of inflammatory necrotic tissue.

Research Excerpts

Excerpt	Relevance	Reference
"Hypertension was induced by DOCA-salt."	1.35	Synthesis and pharmacological investigation of 3-(substituted 1-phenylethanone)-4-(substituted phenyl)-1, 2, 3, 4-tetrahydropyrimidine-5-carboxylates. ( Bhole, RP; Bhusari, KP; Chikhale, RV; Khedekar, PB, 2009)

Trial			Phase	Enrollment	Study Type	Start Date	Status
A Randomized, Single-blinded Placebo-controlled Trial of Ischemic Preconditioning in Raynaud's Phenomenon (RP)[NCT02506062]				21 participants (Actual)	Interventional	2015-07-31	Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

3 reviews available for nifedipine and Ulcer

Article	Year
Raynaud's phenomenon (primary). BMJ clinical evidence, 2013, Oct-10, Volume: 2013 Topics: Administration, Oral; Humans; Nifedipine; Prevalence; Raynaud Disease; Ulcer; Vibration	2013
Raynaud's phenomenon (primary). BMJ clinical evidence, 2008, Dec-16, Volume: 2008 Topics: Administration, Oral; Humans; Nifedipine; Prevalence; Raynaud Disease; Ulcer; Vibration	2008
Raynaud's phenomenon (primary). BMJ clinical evidence, 2011, Mar-14, Volume: 2011 Topics: Administration, Oral; Humans; Nifedipine; Prevalence; Raynaud Disease; Ulcer; Vibration	2011

1 other study available for nifedipine and Ulcer

Article	Year
Synthesis and pharmacological investigation of 3-(substituted 1-phenylethanone)-4-(substituted phenyl)-1, 2, 3, 4-tetrahydropyrimidine-5-carboxylates. European journal of medicinal chemistry, 2009, Volume: 44, Issue:9 Topics: Analgesics; Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Blood Pressure; Edema; Hyper	2009